STAAR Surgical Company
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.4% | 41.9% | 28.0% | -10.5% | 4.3% | 1.3% | -13.5% | -61.5% | 2.8% | -6.8% | -23.2% | 21.1% | -1.0% | |
| 1.7% | 1.8% | 1.6% | 1.5% | 2.0% | 4.9% | 5.5% | 4.5% | 2.1% | 4.2% | 2.4% | 3.6% | 2.9% | |
| 11.0% | 0.2% | 8.2% | 9.1% | 8.1% | 9.5% | 14.1% | 17.6% | 8.6% | 14.9% | 5.2% | 7.0% | 8.3% | |
| -27.3% | 26.8% | 21.7% | -29.8% | -21.8% | 52.3% | 69.0% | -35.8% | -32.5% | 1.6% | -45.6% | -2.9% | -22.2% | |
| 11.4% | 4.0% | 6.7% | 6.3% | 7.0% | 11.7% | 3.4% | 4.0% | 0.9% | 2.9% | 0.5% | 0.5% | 1.0% | |
| 39.6% | 29.4% | 20.9% | -20.9% | -39.8% | -39.8% | 83.0% | 56.7% | 5.6% | -33.6% | 2.3% | -1.5% | -3.9% | |
| 9.0% | 11.5% | – | – | – | – | – | – | – | – | – | – | – | |
| -0.1% | -2.7% | -1.6% | -0.2% | 0.0% | -0.2% | -3.0% | -10.1% | -2.1% | -0.3% | -2.0% | -2.9% | -2.0% | |
| – | – | – | – | 0.0% | -0.1% | -0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 8.8% | 0.5% | 5.2% | 0.2% | 1.8% | -0.2% | -2.2% | -10.2% | 1.0% | -0.1% | -1.8% | -1.6% | -0.7% | |
| 40.8% | 72.9% | 53.0% | -31.6% | -32.5% | -40.5% | 68.0% | -13.5% | 9.5% | -39.8% | -22.8% | 17.9% | -5.5% | |
| -18.9% | 37.9% | 21.3% | -16.8% | -2.7% | -10.4% | -16.9% | -65.5% | 1.9% | -9.7% | -23.7% | 20.5% | -2.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.